Literature DB >> 1814303

Fetal echocardiography: indications for referral, prenatal diagnoses, and outcomes.

N A Callan1, M Maggio, S Steger, J S Kan.   

Abstract

Three hundred three fetuses were studied with fetal echocardiography and 21 were diagnosed with congenital heart disease (CHD). Indications for study, prenatal findings, and postnatal outcomes were examined in all fetuses studied. The most common indications for referral were previous family history and fetal dysrhythmia. Of 189 fetuses studied for these indications, six had CHD. Indications with the highest proportion of abnormal studies included an abnormal four-chamber view of the heart (50% abnormal), fetal hydrops (30.8% abnormal), and polyhydramnios (25% abnormal). Five of 21 with CHD had chromosomal defects and eight had extracardiac anomalies. Two of the 21 fetuses with CHD survived. Present referral indications led to the diagnosis of the most severe lesions, yet reassurance is provided to many couples with normal fetuses. Fetal echocardiography is important in the care of the fetus at risk for CHD.

Entities:  

Mesh:

Year:  1991        PMID: 1814303     DOI: 10.1055/s-2007-999423

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  3 in total

Review 1.  The clinical spectrum of autoimmune congenital heart block.

Authors:  Pilar Brito-Zerón; Peter M Izmirly; Manuel Ramos-Casals; Jill P Buyon; Munther A Khamashta
Journal:  Nat Rev Rheumatol       Date:  2015-03-24       Impact factor: 20.543

2.  Who should be referred? An evaluation of referral indications for fetal echocardiography in the detection of structural congenital heart disease.

Authors:  Lydia Wright; Nanci Stauffer; Cyrus Samai; Matthew Oster
Journal:  Pediatr Cardiol       Date:  2014-02-15       Impact factor: 1.655

3.  Determining the factors causing delayed referral for fetal echocardiography at a tertiary care hospital.

Authors:  Asma Kanwal; Abdul Malik Sheikh; Tayyaba Saher
Journal:  J Saudi Heart Assoc       Date:  2017-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.